文献速递胸部CT

基线低剂量CT肺癌筛查中肺气肿预测长达25年后的慢性阻塞性肺疾病和心血管疾病死亡

Emphysema at Baseline Low-Dose CT Lung Cancer Screening Predicts Death from Chronic Obstructive Pulmonary Disease and Cardiovascular Disease Up to 25 Years Later.
PubMed 文献 · Radiology · 2025-01-01

这项前瞻性队列研究纳入9047名无症状吸烟成人,在2000年6月至2008年12月间接受基线低剂量CT肺癌筛查,肺气肿按0至3分视觉评分,随访至死亡或2024年12月31日,中位随访23.3年。基线肺气肿独立预测全因死亡(HR 1.29)、COPD死亡(HR 3.29)和CVD死亡(HR 1.14);竞争风险分析中肺气肿仍与COPD死亡相关(HR 3.06),但与CVD死亡无显著关联(HR 1.04,95%CI 0.91-1.18,P=.59)。

要点

  • 基线LDCT视觉肺气肿评分可预测长达25年的全因死亡和COPD死亡,且存在剂量-反应关系。
  • 肺气肿与CVD死亡的关联在竞争风险分析中未达统计学显著(HR 1.04,95%CI 0.91-1.18)。
  • 9047名参与者中29.1%有肺气肿,重度者仅2.4%,阅片时对轻中度肺气肿的评分即具预后意义。

核心结论

  • 在无症状成人前瞻性肺癌筛查队列中,基线LDCT肺气肿可预测长达25年后的全因死亡、COPD死亡和CVD死亡。

研究设计与样本

  • 前瞻性队列研究,纳入9047名40-85岁有吸烟史的无症状成人,2000年6月至2008年12月接受基线LDCT肺癌筛查,随访至死亡、失访或2024年12月31日。

关键影像表现/征象

  • 肺气肿由四名经验丰富的胸部放射科医师之一在基线LDCT上视觉评分,0分为无,3分为重度。
  • 2637名(29.1%)有肺气肿,其中轻度1908名(21.1%)、中度512名(5.7%)、重度217名(2.4%)。
  • 肺气肿严重程度与全因死亡和COPD死亡呈剂量-反应关系,但与CVD死亡无剂量-反应关系。

诊断标准与关键数值

  • 肺气肿视觉评分0至3分:0分为无,1分为轻度,2分为中度,3分为重度。
  • 肺气肿预测全因死亡HR 1.29(95%CI 1.21-1.38,P<.001),COPD死亡HR 3.29(95%CI 2.59-4.18,P<.001),CVD死亡HR 1.14(95%CI 1.01-1.29,P=.04)。
  • 调整竞争风险模型中,肺气肿与COPD死亡相关HR 3.06(95%CI 2.40-3.90,P<.001),与CVD死亡无显著关联HR 1.04(95%CI 0.91-1.18,P=.59)。

临床应用与阅片要点

  • 在肺癌筛查LDCT报告中,可对肺气肿进行0至3分视觉评分,该评分对长期全因死亡和COPD死亡有预后提示价值。
  • 报告肺气肿时需注明严重程度分级,因轻中度肺气肿已占本队列的21.1%和5.7%,且与死亡风险相关。

局限性

  • 基线吸烟史和合并症为自我报告。
  • 肺气肿由四名放射科医师之一进行视觉评分,原文未报告评分者间一致性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background The prognostic value of baseline visual emphysema scoring at low-dose CT (LDCT) in lung cancer screening cohorts is unknown. Purpose To determine whether a single visual emphysema score at LDCT is predictive of 25-year mortality from all causes, chronic obstructive pulmonary disease (COPD), and cardiovascular disease (CVD). Materials and Methods In this prospective cohort study, asymptomatic adults aged 40-85 years with a history of smoking underwent baseline LDCT screening for lung cancer between June 2000 and December 2008. Follow-up continued until death, loss to follow-up, or December 31, 2024. Emphysema was assessed at baseline LDCT and scored from 0 (none) to 3 (severe) by one of four experienced chest radiologists. Baseline smoking history and comorbidities were self-reported. Causes of death (International Classification of Diseases, 10th Revision) were obtained from the U.S. National Death Index, physicians, and family. Associations between emphysema and mortality were evaluated using adjusted Cox proportional hazards and adjusted Fine-Gray competing risks models. Results Among 9047 participants (4614 female; median age, 65 years [IQR, 61-69 years]; median pack-years of smoking, 43 [IQR, 28-64]), 2637 (29.1%) had emphysema (mild in 1908 [21.1%], moderate in 512 [5.7%], and severe in 217 [2.4%]). Median follow-up was 23.3 years. Emphysema was independently predictive of all-cause mortality (hazard ratio [HR], 1.29; 95% CI: 1.21, 1.38; P < .001), COPD mortality (HR, 3.29; 95% CI: 2.59, 4.18; P < .001), and CVD mortality (HR, 1.14; 95% CI: 1.01, 1.29; P = .04). A dose-response relationship was observed between emphysema severity and both all-cause and COPD mortality, but not CVD mortality. In the adjusted competing risk analysis, emphysema remained associated with COPD mortality (HR, 3.06; 95% CI: 2.40, 3.90; P < .001), but not CVD mortality (HR, 1.04; 95% CI: 0.91, 1.18; P = .59). Conclusion Baseline emphysema at LDCT in a prospective lung cancer screening cohort of asymptomatic adults was predictive of all-cause, COPD, and CVD mortality up to 25 years later. © RSNA, 2025 Supplemental material is available for this article. See also the editorial by Mascalchi and Diciotti in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. González Gutiérrez J, Yip R, Zulueta JJ, et al. Emphysema at Baseline Low-Dose CT Lung Cancer Screening Predicts Death from Chronic Obstructive Pulmonary Disease and Cardiovascular Disease Up to 25 Years Later. Radiology. 2025. PMID: 40923882. doi:10.1148/radiol.250949

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。